NCM Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

NCM Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$315K	Hold	1,865	–	–	0.11%	149
2025 Q4	$315K	Hold	1,865	–	–	0.12%	147
2025 Q3	$269K	Hold	1,865	–	–	0.1%	152
2025 Q2	$236K	Hold	1,865	–	–	0.1%	162
2025 Q1	$239K	Hold	1,865	–	–	0.11%	156
2024 Q4	$247K	Hold	1,865	–	–	0.11%	154
2024 Q3	$272K	Hold	1,865	–	–	0.13%	141
2024 Q2	$256K	Hold	1,865	–	–	0.13%	138
2024 Q1	$256K	Hold	1,865	–	–	0.14%	136
2023 Q4	$253K	Sell	1,865 -170	-8%	-$20.7K	0.15%	135
2023 Q3	$249K	Hold	2,035	–	–	0.18%	127
2023 Q2	$258K	Buy	2,035 +20	+1%	+$2.6K	0.18%	127
2023 Q1	$260K	Hold	2,015	–	–	0.19%	124
2022 Q4	$265K	Hold	2,015	–	–	0.17%	141
2022 Q3	$236K	Hold	2,015	–	–	0.18%	147
2022 Q2	$237K	Hold	2,015	–	–	0.17%	151
2022 Q1	$263K	Hold	2,015	–	–	0.17%	157
2021 Q4	$308K	Buy	+2,015	New	+$312K	0.27%	109

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NCM Capital Management's IBB Position: Q1 2026 in Review

NCM Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,865 shares worth $315K. The position accounts for 0.11% of the portfolio, ranked #149.

NCM Capital Management first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

NCM Capital Management held 1,865 shares of iShares Biotechnology ETF worth $315K as of Q1 2026.
NCM Capital Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.11% of NCM Capital Management's portfolio in Q1 2026, its #149 holding.
NCM Capital Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.